In a study of 10 patients, the LYNX LIO achieved a mean treatment time of 16 minutes, 43 seconds, with 3,489 spots delivered ...

This noninvasive imaging tool reveals early brain pathology through the eye, promising faster and more accurate diagnoses as highlighted at the 2025 International SPECTRALIS Symposium – And Beyond ...

NASA’s development of autonomous eye imaging technologies for astronauts aboard the International Space Station is paving the ...

Funding will support the continued clinical advancement of its lead ocular implant candidate, PA5108, for the reduction of ...

Improved axial resolution allows clearer visualization of early atrophic changes, including iRORA vs cRORA differentiation, as shared at the Heidelberg 2025 International SPECTRALIS Symposium – And ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Cabozantinib is a vascular endothelial growth factor receptor tyrosine kinase inhibitor, a drug used as a therapy for several ...

The rationale for the study under discussion is that the experience level of the operating surgeon is a potential factor ...

EssilorLuxottica and MidEuropa recently entered into an agreement that will allow EssilorLuxottica to acquire Optegra, ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Advanced autofluorescence reveals cellular pigment reservoirs with therapeutic potential at the 2025 International Spectralis Symposium – and Beyond.